LENZ Therapeutics, Inc. (LENZ)
10.06
+0.34
(+3.50%)
USD |
NASDAQ |
May 08, 16:00
10.10
+0.04
(+0.40%)
After-Hours: 20:00
LENZ Therapeutics EPS Diluted (Quarterly) : -1.155 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Maze Therapeutics, Inc. | -0.7007 |
| CDT Equity, Inc. | -231.44 |
| Liminatus Pharma, Inc. | -0.3018 |
| Oruka Therapeutics, Inc. | -0.5436 |
| MapLight Therapeutics, Inc. | -1.807 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.90M |
| Revenue (Quarterly) | 1.588M |
| Total Expenses (Quarterly) | 37.48M |
| Enterprise Value | 23.89M |
| Gross Profit Margin (Quarterly) | 66.94% |
| Profit Margin (Quarterly) | -2.26K% |
| Earnings Yield | -27.86% |
| Normalized Earnings Yield | -27.86 |